Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125721101 | 12572110 | 1 | I | 20160301 | 20160715 | 20160719 | 20160719 | EXP | GB-MHRA-EYC 00142289 | PHFR2016GB005851 | NOVARTIS | 76.00 | YR | F | Y | 0.00000 | 20160719 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125721101 | 12572110 | 1 | PS | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 4 MG, UNK | U | UNKNOWN | 21223 | 4 | MG | SOLUTION FOR INJECTION | |||||
125721101 | 12572110 | 2 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | U | 0 | ||||||||||
125721101 | 12572110 | 3 | C | DEXAMETASON | DEXAMETHASONE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125721101 | 12572110 | 1 | Plasma cell myeloma |
125721101 | 12572110 | 2 | Product used for unknown indication |
125721101 | 12572110 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125721101 | 12572110 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125721101 | 12572110 | Osteonecrosis of jaw |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125721101 | 12572110 | 1 | 20140801 | 0 |